Synthetic Scrapie Infectivity: Interaction between Recombinant PrP and Scrapie Brain-Derived RNA

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Fournier JG. Cellular prion protein electron microscopy: attempts/limits and clues to a synaptic trait. Implications in neurodegeneration process. Cell Tissue Res 2008; 332:1-11; PMID:18236081; http://dx.doi.org/10.1007/s00441-007-0565-5
   PubMed Web of Science ®Google Scholar
• Somerville RA, Merz PA, Carp RI. Partial copurification of scrapie-associated fibrils and scrapie infectivity. Intervirology 1986; 25:48-55; PMID:2422138; http://dx.doi.org/10.1159/000149654
   PubMed Web of Science ®Google Scholar
• Merz PA, Kascsak RJ, Rubenstein R, Carp RI, Wisniewski HM. Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol 1987; 61:42-9; PMID:2878092
   PubMedGoogle Scholar
• Safar J, Ceroni M, Piccardo P, Liberski PP, Miyazaki M, Gajdusek DC, et al. Subcellular distribution and physicochemical properties of scrapie-associated precursor protein and relationship with scrapie agent. Neurology 1990; 40:503-8; PMID:1969124; http://dx.doi.org/10.1212/WNL.40.3_Part_1.503
   PubMed Web of Science ®Google Scholar
• Merz PA, Somerville RA, Wisniewski HM, Manuelidis L, Manuelidis EE. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. CA>Nature 1983; 306:474-6.
   PubMed Web of Science ®Google Scholar
• Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275:402-5; PMID:8994041; http://dx.doi.org/10.1126/science.275.5298.402
   PubMed Web of Science ®Google Scholar
• Piccardo P, Manson JC, King D, Ghetti B, Barron RM. Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 2007; 104:4712-7; PMID:17360589; http://dx.doi.org/10.1073/pnas.0609241104
   PubMed Web of Science ®Google Scholar
• Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007; 282:35878-86; PMID:17923484; http://dx.doi.org/10.1074/jbc.M704329200
   PubMed Web of Science ®Google Scholar
• Race R, Meade-White K, Raines A, Raymond GJ, Caughey B, Chesebro B. Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 2002; 186 Suppl 2:S166-70; PMID:12424693; http://dx.doi.org/10.1086/344267
   PubMed Web of Science ®Google Scholar
• Balkema-Buschmann A, Eiden M, Hoffmann C, Kaatz M, Ziegler U, Keller M, et al. BSE infectivity in the absence of detectable PrP(Sc) accumulation in the tongue and nasal mucosa of terminally diseased cattle. J Gen Virol 2011; 92:467-76; PMID:20943888; http://dx.doi.org/10.1099/vir.0.025387-0
   PubMed Web of Science ®Google Scholar
• Manuelidis L, Fritch W, Xi YG. Evolution of a strain of CJD that induces BSE-like plaques. Science 1997; 277:94-8; PMID:9204907; http://dx.doi.org/10.1126/science.277.5322.94
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Kipkorir T, Tittman S, Manuelidis L. Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease. PLoS One 2012; 7:e35471; PMID:22509412; http://dx.doi.org/10.1371/journal.pone.0035471
   PubMed Web of Science ®Google Scholar
• Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 2010; 119:177-87; PMID:20052481; http://dx.doi.org/10.1007/s00401-009-0633-x
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5; PMID:20110469; http://dx.doi.org/10.1126/science.1183748
   PubMed Web of Science ®Google Scholar
• Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083-7; PMID:20304915; http://dx.doi.org/10.1074/jbc.C110.113464
   PubMed Web of Science ®Google Scholar
• Miller MB, Wang DW, Wang F, Noble GP, Ma J, Woods VL, Jr., et al. Cofactor molecules induce structural transformation during infectious prion formation. Structure 2013; 21:2061-8; PMID:24120764; http://dx.doi.org/10.1016/j.str.2013.08.025
   PubMed Web of Science ®Google Scholar
• Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425:717-20; PMID:14562104; http://dx.doi.org/10.1038/nature01979
   PubMed Web of Science ®Google Scholar
• Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21:1031-40; PMID:11867531; http://dx.doi.org/10.1093/emboj/21.5.1031
   PubMed Web of Science ®Google Scholar
• Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 2010; 49:3928-34; PMID:20377181; http://dx.doi.org/10.1021/bi100370b
   PubMed Web of Science ®Google Scholar
• Grassmann A, Wolf H, Hofmann J, Graham J, Vorberg I. Cellular aspects of prion replication in vitro. Viruses 2013; 5:374-405; PMID:23340381; http://dx.doi.org/10.3390/v5010374
   PubMed Web of Science ®Google Scholar
• Abid K, Morales R, Soto C. Cellular factors implicated in prion replication. FEBS Lett 2010; 584:2409-14; PMID:20412808; http://dx.doi.org/10.1016/j.febslet.2010.04.040
   PubMed Web of Science ®Google Scholar
• Timmes AG, Moore RA, Fischer ER, Priola SA. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One 2013; 8:e71081.
   PubMed Web of Science ®Google Scholar
• Soto C. Prion hypothesis: the end of the controversy? Trends Biochem Sci 2011; 36:151-8; PMID:21130657; http://dx.doi.org/10.1016/j.tibs.2010.11.001
   PubMed Web of Science ®Google Scholar
• Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, et al. Search for a prion-specific nucleic acid. J Virol 2005; 79:10796-806; PMID:16051871; http://dx.doi.org/10.1128/JVI.79.16.10796-10806.2005
   PubMed Web of Science ®Google Scholar
• German TL, McMillan BC, Castle BE, Dees C, Wade WF, Marsh RF. Comparison of RNA from healthy and scrapie-infected hamster brain. J Gen Virol 1985; 66 ( Pt 4):839-44; PMID:2580051; http://dx.doi.org/10.1099/0022-1317-66-4-839
   PubMed Web of Science ®Google Scholar
• Dees C, McMillan BC, Wade WF, German TL, Marsh RF. Characterization of nucleic acids in membrane vesicles from scrapie-infected hamster brain. J Virol 1985; 55:126-32; PMID:2409296
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Emmerling K, Manuelidis L. High CJD infectivity remains after prion protein is destroyed. J Cell Biochem 2011; 112:3630-7; PMID:21793041; http://dx.doi.org/10.1002/jcb.23286
   PubMed Web of Science ®Google Scholar
• Pritzkow S, Wagenfuhr K, Daus ML, Boerner S, Lemmer K, Thomzig A, et al. Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One 2011; 6:e20384; PMID:21647368; http://dx.doi.org/10.1371/journal.pone.0020384
   PubMed Web of Science ®Google Scholar
• Beekes M, Baldauf E, Cassens S, Diringer H, Keyes P, Scott AC, et al. Protein gel blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method. J Gen Virol 1995; 76 ( Pt 10):2567-76; PMID:7595360; http://dx.doi.org/10.1099/0022-1317-76-10-2567
   PubMed Web of Science ®Google Scholar
• Herzog C, Sales N, Etchegaray N, Charbonnier A, Freire S, Dormont D, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004; 363:422-8; PMID:14962521; http://dx.doi.org/10.1016/S0140-6736(04)15487-1
   PubMed Web of Science ®Google Scholar
• Thomzig A, Spassov S, Friedrich M, Naumann D, Beekes M. Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol Chem 2004; 279:33847-54; PMID:15155741; http://dx.doi.org/10.1074/jbc.M403730200
   PubMed Web of Science ®Google Scholar
• Lewis V, Haigh CL, Masters CL, Hill AF, Lawson VA, Collins SJ. Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. Mol Neurodegener 2012; 7:18; PMID:22534096; http://dx.doi.org/10.1186/1750-1326-7-18
   PubMed Web of Science ®Google Scholar
• Dobie K, Barron R. Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease. J Virol 2013; 87:5895-903; PMID:23487470; http://dx.doi.org/10.1128/JVI.03469-12
   PubMed Web of Science ®Google Scholar
• Geoghegan JC, Valdes PA, Orem NR, Deleault NR, Williamson RA, Harris BT, et al. Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem 2007; 282:36341-53; PMID:17940287; http://dx.doi.org/10.1074/jbc.M704447200
   PubMed Web of Science ®Google Scholar
• Akowitz A, Manuelidis EE, Manuelidis L. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease. Arch Virol 1993; 130:301-16; PMID:8517790; http://dx.doi.org/10.1007/BF01309662
   PubMed Web of Science ®Google Scholar
• Forster E, Zhao S, Frotscher M. Laminating the hippocampus. Nat Rev Neurosci 2006; 7:259-67; PMID:16543914; http://dx.doi.org/10.1038/nrn1882
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439-77; PMID:18558863; http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620
   PubMed Web of Science ®Google Scholar
• Fournier JG, Escaig-Haye F, Billette de Villemeur T, Robain O. Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. C R Acad Sci III 1995; 318:339-44; PMID:7788502
   PubMed Web of Science ®Google Scholar
• Siskova Z, Perry VH, Asuni AA. Prion Protein Misfolding at the Synapse. In: Wyttenbach A, O'Connors V, eds. Folding for the Synapse: Springer, 2011:289-312.
   Google Scholar
• Kipkorir T, Tittman S, Botsios S, Manuelidis L. Highly Infectious CJD Particles Lack Prion Protein but Contain Many Viral-Linked Peptides by LC-MS/MS. J Cell Biochem 2014; 115:2012-21; PMID:24933657
   PubMed Web of Science ®Google Scholar
• Fournier JG. Is RNA Critical for the Production of TSE Infection? Front Psychiatry 2010; 1:24; PMID:21423435; http://dx.doi.org/10.3389/fpsyt.2010.00024
   PubMedGoogle Scholar
• Manuelidis L. Infectious particles, stress, and induced prion amyloids: a unifying perspective. Virulence 2013; 4:373-83; PMID:23633671; http://dx.doi.org/10.4161/viru.24838
   PubMed Web of Science ®Google Scholar
• Silva JL, Lima LM, Foguel D, Cordeiro Y. Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem Sci 2008; 33:132-40; PMID:18243708; http://dx.doi.org/10.1016/j.tibs.2007.11.003
   PubMed Web of Science ®Google Scholar
• Supattapone S. Biochemistry. What makes a prion infectious? Science 2010; 327:1091-2; PMID:20185716; http://dx.doi.org/10.1126/science.1187790
   PubMed Web of Science ®Google Scholar
• Saa P, Sferrazza GF, Ottenberg G, Oelschlegel AM, Dorsey K, Lasmezas CI. Strain-specific role of RNAs in prion replication. J Virol 2012; 86:10494-504; PMID:22811520; http://dx.doi.org/10.1128/JVI.01286-12
   PubMed Web of Science ®Google Scholar
• Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:e125; PMID:17784787
   PubMed Web of Science ®Google Scholar
• Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science 2004; 305:673-6; PMID:15286374; http://dx.doi.org/10.1126/science.1100195
   PubMed Web of Science ®Google Scholar
• Thomzig A, Kratzel C, Lenz G, Kruger D, Beekes M. Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 2003; 4:530-3; PMID:12776740; http://dx.doi.org/10.1038/sj.embor.embor827
   PubMed Web of Science ®Google Scholar